PwC detailed some of the factors that will steer M&A decisions in 2026. Amid policy uncertainty, buyers are demonstrating disciplined capital deployment. Regulators and lawmakers are taking a hard ...

Private equity-owned medical supplies giant Medline is aiming to raise up to $7 billion in an upsized share sale, the Financial Times reported on Tuesday, citing people briefed on the talks.

Starton Holdings plans $40M IPO for cancer drug delivery innovations, but weak IP and limited backing make this a potentially ...

Lumexa Imaging hauled in $462.5 million during its initial public offering, far exceeding the $200 million the outpatient ...

The startup's new tech could compete with Big Tech's health AI projects from heavyweights like Alphabet and OpenAI.

In this week’s edition of InnovationRx, Medline’s blockbuster IPO, Fred Moll’s surgical robotics investments, Forbes' ...

Lumexa Imaging, one of the largest U.S. diagnostic imaging services providers, said on Wednesday it has raised $462.5 million ...

Medline (MDLN) targets a record-breaking $5.37B IPO as the medical product maker and distributor seeks over $55B valuation in ...

QingSong Health Corporation wants to raise up to 601.9 million Hong Kong dollars, equivalent to US$77.3 million, by issuing 26.5 million shares at HK$22.68 each. Hanx Biopharmaceuticals wants to raise ...

Medline Inc.’s long-delayed initial public offering is on track to raise the most of any listing this year, as investors keen ...

Medline Inc. is guiding prospective investors to expect its IPO to price in the upper half of the marketed range, according ...

Medline is planning an IPO, which might occur between late 2025 and early 2026, aiming for a $5 billion raise. Investors can't buy Medline stock now; consider similar public firms like Cardinal Health ...